Applicant, as named in the Orange Book

Tarsus

Next listed expiry: Xdemvy on 14 Dec 2038. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xdemvy lotilaner	lotilaner	217603	14 Dec 2038	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.